Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
today announced that the company will participate at several upcoming
conferences. The presentation details are as follows:
-
Deutsche Bank 39th Annual Healthcare Conference on
Wednesday, May 7, 2014 at 9:20 a.m. ET at The InterContinental Hotel
in Boston, MA
-
Cancer Advance New York conference, taking place May 13-14, 2014, at
Apella in New York City
A webcast of the Deutsche Bank presentation can be accessed by visiting
the investors section of the Company’s website at www.verastem.com.
A replay will be archived on the Verastem website for 90 days following
the presentation date.
About Verastem, Inc.
Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to
treat cancer by the targeted killing of cancer stem cells. Cancer stem
cells are an underlying cause of tumor recurrence and metastasis.
Verastem is developing small molecule inhibitors of signaling pathways
that are critical to cancer stem cell survival and proliferation: FAK,
PI3K/mTOR and Wnt. For more information, please visit www.verastem.com.
Forward-looking statements:
Any statements in this press release about future expectations, plans
and prospects for the Company constitute forward-looking statements
within the meaning of The Private Securities Litigation Reform Act of
1995. Actual results may differ materially from those indicated by such
forward-looking statements. The Company anticipates that subsequent
events and developments will cause the Company’s views to change.
However, while the Company may elect to update these forward-looking
statements at some point in the future, the Company specifically
disclaims any obligation to do so.
Copyright Business Wire 2014